Raymond James & Associates Bioventus Inc. Transaction History
Raymond James & Associates
- $161 Billion
- Q3 2024
A detailed history of Raymond James & Associates transactions in Bioventus Inc. stock. As of the latest transaction made, Raymond James & Associates holds 11,498 shares of BVS stock, worth $134,641. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,498Holding current value
$134,641% of portfolio
0.0%Shares
6 transactions
Others Institutions Holding BVS
# of Institutions
142Shares Held
45.9MCall Options Held
179KPut Options Held
124K-
Essex Woodlands Management, Inc. The Woodlands, TX13MShares$152 Million44.65% of portfolio
-
Juniper Investment Company, LLC New York, NY6.94MShares$81.3 Million33.68% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT4.35MShares$50.9 Million3.09% of portfolio
-
Black Rock Inc. New York, NY2.37MShares$27.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.07MShares$24.3 Million0.0% of portfolio
About Bioventus Inc.
- Ticker BVS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 61,664,200
- Market Cap $722M
- Description
- Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...